He received his medical degree from Northeastern Ohio Medical University. His internal medicine and hematology/oncology training was completed at Case Western Reserve University where he also served as Chief Medical Resident. Joining the University of Rochester lymphoma program in 2010, his primary research focus is on novel drug development for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Dr. Barr’s current efforts revolve around the development of novel combinations incorporating inhibitors targeting the B cell receptor signaling pathway and are supported by a career development grant awarded by the Lymphoma Research Foundation.